All drug development articles
-
SponsoredPharmaceutical impurities: Combatting pharma’s elusive threat
Small molecule manufacturer Toronto Research Chemicals helps drug formulators eliminate impurities in the development pipeline, ensuring safer products make it to market
-
Webinar
Developing small-molecule degraders using chemoproteomics
Discover how chemoproteomics can inform the development of small molecule degraders
-
Sponsored
Catalysis and chemical bonds that make us stronger
Chemical and pharma industry is built on collaboration that draws on a wide range of expertise to develop innovative materials, compounds and components
-
Podcast
Cimetidine
Mike Freemantle introduces the peptic ulcer treatment cimetidine, which – as Tagamet – became the first blockbuster drug
-
Podcast
Fexinidazole
The World Health Organisation hope to eradicate sleeping sickness within our lifetimes. Jamie Durrani looks at a drug that may make it possible.
-
Sponsored
Cultivating innovation in the UK’s life science industry
Scientific and digital collaboration is key to maintaining the UK’s esteemed status in global life sciences and pharma circles. CPI exists to facilitate and underpin those vital relationships
-
Sponsored
Ageing populations and the medicines of tomorrow
Drug particle engineering is set to revolutionise medicine and provide solutions to the world’s biggest healthcare challenges. Scientific innovator Nanoform is a vital part of that movement. Here’s why
-
Sponsored
Seeking part-time scientists with GMP skills
Experienced scientists who opt to work part time are so beneficial to Reading Scientific Service Ltd that the company wants more of them
-
Sponsored
Johnson Matthey enzyme technology for a clean and healthy tomorrow
Enzymes have evolved into nature’s reaction facilitators over millions of years and their unique catalytic abilities drive science by connecting essential life elements
-
Webinar
Synthia: Retrosynthesis software for research chemists
This computer-aided approach efficiently searches possible pathways for target molecules to accelerate drug discovery
-
Research
New ligand removes uranium from bones
A treatment that mops up uranium in the bones and kidneys of mice could help humans exposed to radiation
-
News
Vaccines central to efforts to head off latest Ebola outbreak
Ring vaccination strategy could halt disease in its tracks provided health systems can cope
-
Sponsored
Sygnature Discovery
Sygnature Discovery is part of an innovative partnership to bolster the life science sector in Nottingham
-
Sponsored
Analytical method transfer
Learn about current best practice in a critical field for the industry
-
Research
Drug binding simulations promise to get personal
Fast, reliable new molecular dynamic simulation methods set to speed up research are under investigation by GSK
-
Research
Route to complex amines holds drug development promise
New catalytic reaction yields products with three adjacent chiral centres
-
Opinion
How to solve global health inequality
Our skills as scientists hold the answer, says the Bill & Melinda Gates Foundation
-
Research
Synthetic stomach membrane to minimise animal tests
Researchers strive to replace lab animals with hydrogel models
-
-
News
Pharma should 'double output by 2022'
US report says pharma industry must set itself an ambitious target for drug development
